Research Opportunities (Apply for Funding)

Neurofibromatosis Therapeutic Acceleration Program (NTAP) is dedicated to improving treatment options for patients with neurofibromatosis type 1 (NF1)-associated plexiform neurofibromas (pNFs) and cutaneous neurofibromas (cNFs). We work with investigators around the world to ensure research has the funding, resources and strategic focus necessary to understand the disease and develop effective therapies against these tumors.

NTAP invites proposals for targeted areas of research via announcements posted to this website and distributed within the scientific community several times per year.

NTAP also invites proposals from all investigators (regardless of their location or primary research focus) who have compelling research projects designed to accelerate the development of effective treatments for pNFs and cNFs to apply through the Open Applications process.